Search Results for:
-
3-WAY COLLABORATION FOR AIDS RESEARCH
According to Agouron spokeswoman Donna Nichols, the San Diego company will provide the structure of the target enzyme, reverse transcriptase, while NeXagen and Selectide will use their technologies to find leads for possible drug candidatesBioWorld Today | Thursday, September 10, 1992 -
LIGAND, GLAXO TO DEVELOP HEART DRUGS
unit of London-based Glaxo Holdings plc, is picking up much of the research costs and also agreed to make a $10 million equity investment in the San Diego-based developer of receptor-based drugsBioWorld Today | Thursday, September 10, 1992 -
MOLECULAR BIO ALLOWED CONTINUATION IN PART
The San Diego company received a patent for the agent in AprilBioWorld Today | Thursday, September 10, 1992 -
DIABETICS FOUND DEFICIENT IN AMYLIN
Andrew Young and Christopher Moyses of Amylin Pharmaceuticals of San Diego made their report at a company- sponsored workship entitled "Amylin: Biological Activity and Therapeutic Potential," Amylin Pharmaceuticals believes that amylin plays a major role in the regulation of carbohydrate metabolism and that amylin discoveries will lead to diabetes treatmentsBioWorld Today | Wednesday, September 9, 1992 -
GENTA COLLABORATION WITH WYETH-AYERST
The San Diego company said it expects to file a total of five INDs this yearBioWorld Today | Wednesday, September 9, 1992 -
ARTHRITIS VACCINE BEGINS TRIALS
Basta told BioWorld that the San Diego company intends to develop its rheumatoid arthritis vaccine independently and is not looking for a licensing partnerBioWorld Today | Wednesday, September 9, 1992 -
DURA LAUNCHES FIRST PATENTED DRUG
Dura of San Diego (NASDAQ: DURA) holds worldwide marketing rights, excluding in Italy, for Tornalate Inhalation SolutionBioWorld Today | Wednesday, September 9, 1992 -
EUROPEAN PATENT DISCLOSURES
Coleopteran-active EPO 500 311 San Diego Bt Toxin Bacillus thuringiensis isolates against corn rootworm larvae, alfalfa weevilBioWorld Today | Tuesday, September 8, 1992 -
MACCONNELL WINS SECOND NIH GRANT
The National Science Foundation has awarded MacConnell Research of San Diego a two-year small business innovative research (SBIR) Phase II grantBioWorld Today | Friday, September 4, 1992 -
GEN-PROBE, MOLECULAR BIOSYSTEMS SETTLE SUIT
and Molecular Biosystems (NYSE:MB), both of San Diego, Calif., announced Monday they have settled their patent litigation concerning diagnostic test kits using genetic probe technologyBioWorld Today | Tuesday, September 1, 1992 -
ADVANCEMENTS AND APPOINTMENTS
of San Diego, Calif., appointed Richard M. Rose vice president, medical affairs and chief medical officerBioWorld Today | Tuesday, September 1, 1992 -
MYCOGEN COMPLETES $135 MILLION DEAL
Mycogen of San Diego is to hold a 51 percent interest in the partnership, with Lubrizol of Wickliff, Ohio, owning the remainderBioWorld Today | Friday, August 28, 1992 -
APPOINTMENTS AND ADVANCEMENTS
of San Diego elevated Robert L. Widerkehr to president and chief executive officerBioWorld Today | Wednesday, August 26, 1992 -
E. MERCK TO MARKET BIOSITE'S DRUG TEST
Biosite of San Diego launched Triage in the U.SBioWorld Today | Wednesday, August 12, 1992 -
APPOINTMENTS AND ADVANCEMENTS
Foster was a section leader in Merck, Sharpe and Dohme's neuroscience research center and Firestein was assistant professor of medicine in residence at the University of California, San DiegoBioWorld Today | Tuesday, August 11, 1992 -
IXSYS, BIOSITE TEAM TECHNOLOGIES
Two San Diego-based companies, Ixsys IncBioWorld Today | Monday, August 10, 1992 -
GENTA FILES IND FOR PSORIASIS TREATMENT
Albright said the San Diego-based company expects G-301 will enter clinical trials soon after the customary 30-day period following the FDA applicationBioWorld Today | Thursday, August 6, 1992 -
ARMY ENLISTS VIAGENE TO FIGHT MALARIA
believes could be the first application of retroviral gene transfer to the prevention of a parasitic disease, the company announced Tuesday an agreement to work with U.S. Army researchers on vaccines against malaria and other infectious diseases Viagene of San Diego is to supply proprietary retroviral vectors in a collaboration with the Walter Reed Army Institute of Research in Washington, D.CBioWorld Today | Wednesday, August 5, 1992 -
WEST COAST BIOTECH CONFERENCES
The conferences -- in Seattle and San Diego -- have overlapping schedules on Sept...In San Diego, the CalBioSummit '92, scheduled for Friday, SeptBioWorld Today | Monday, August 3, 1992 -
APPOINTMENTS AND ADVANCEMENTS
Foster was a section leader in the Neuroscience Research Centre in Essex, England, and Firestein was assistant professor of medicine in residence at the University of California, San DiegoBioWorld Today | Friday, July 31, 1992
Category
Current Filters
- xSan Diego
Related Keywords
Categories
- x BioWorld Today (7951)
- x BioWorld Insight (610)
- x BioWorld International (416)
- x Bio Perspectives (103)
- x BioWorld Genomics Review (60)
- x State of the Industry Report (44)
- x BioWorld Snapshots (18)
- x Biotech Innovations (11)
- x RNAi Report (3)
- x Market-Leading Biotech Drugs (3)
- x Bioscan (1)
- x Executive Compensation Report (1)
- x Top 25 Drug Report (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.